Clinical Trial Update: DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers [Phase 2, Phase 3]

View source ↗

Summary

The DETERMINE trial treatment arm 01 is evaluating Alectinib in adult, paediatric and teenage/young adult patients with ALK-positive cancers in Phase 2/3, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Lymphoma
• Neuroblastoma
• Renal Cell Carcinoma
• Solid Tumor

Drugs mentioned

• Alectinib (alectinib)

Snippet

Sponsor: Cancer Research UK | Conditions: Haematological Malignancy, Malignant Neoplasm | Phase 2, Phase 3 | Status: RECRUITING